Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Data from Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
Home
Publications
Data from Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
Data from Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
Authors:
JX
Jianming Xu
Jianming Xu
JS
Jie Shen
Jie Shen
SG
Shanzhi Gu
Shanzhi Gu
YZ
Yun Zhang
Yun Zhang
LW
Lihua Wu
Lihua Wu
JW
Jian Wu
Jian Wu
GS
Guoliang Shao
Guoliang Shao
YZ
Yanqiao Zhang
Yanqiao Zhang
LX
Li Xu
Li Xu
TY
Tao Yin
Tao Yin
JL
Jingfeng Liu
Jingfeng Liu
ZR
Zhenggang Ren
Zhenggang Ren
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
31 March 2023
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1078-0432.c.6530222
Abstract
No abstract available
Keywords
APATINIB
CLINICAL ENDPOINT
REFRACTORY (PLANETARY SCIENCE)
PROGRESSION-FREE SURVIVAL
Scroll to top